The American Society for Gastrointestinal Endoscopy recently released new clinical guidance on the screening for pancreatic cancer in people with genetic susceptibility (Gastrointest Endosc 2022 Feb 16. doi:10.1016/j.gie.2021.12.001). GEN’s Sarah Tilyou spoke with lead author Mandeep S. Sawhney, MD, MS, FASGE, a gastroenterologist at Beth Israel Deaconess Medical Center and an associate professor of medicine at Harvard Medical School, in Boston, about the impetus for the guidelines and what they mean to GI practice.
Trending
- Is This the AI Endgame? What Happens to GI?
- The Oral GLP-1 Tracker: Novo’s Wegovy pill, Lilly’s Foundayo continue prescription climb
- Medicare to cover colorectal cancer screenings ordered by PAs, APRNs (Becker’s GI & Endoscopy)
- America Is Running Out of Doctors (The Health Care Blog)
- Weighed Down by Paperwork: Identifying Barriers to Metabolic and Bariatric Surgery Evaluation in the United States (Springer Nature)
- Banning Corporate Medicine: Stopping Private Equity’s Debt Trap (Forbes)
- Colonoscopy Intervals and Colorectal Cancer Incidence after Adenoma Removal (The New England Journal of Medicine)
- Blood test targets ‘Achilles’ heel’ of CRC screening, detects 81% of advanced adenomas (Healio)
